GEN Exclusives

More »

GEN News Highlights

More »
Nov 16, 2012

Thermo Opens New Facility in China

  • Thermo Fisher Scientific is opening a new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment. The firm says the facility expands its global manufacturing footprint and establishes local production capabilities to meet increased customer demand in China and other Asia-Pacific markets.

    Thermo Fisher has invested nearly $20 million in the 12,000-square-meter Suzhou plant. The new facility will primarily serve the life sciences and pharmaceutical industries including research, diagnostics, and bioproduction. There, the company will manufacture plastic labware and consumables including sample preparation products and filterware, as well as laboratory refrigerators, freezers, incubators, and centrifuges.

    “China is one of our fastest-growing markets and has been a key contributor to our success,” says Marc N. Casper, Thermo’s president and CEO. “The Suzhou facility builds on our well-established presence in China and is an important next step as we closely align our depth of capabilities with China’s five-year plan to develop strategic industries including pharmaceutical, healthcare, and environmental.”

    Suzhou is home to BioBay, a 86.3-hectare industrial park for the biotech and nanotech industries. It began operations in June 2007 and has helped make Suzhou an emerging biotech cluster in China.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »